Zenotech Laboratories
Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo
Sun Pharma said it will pay Rs 5.32 crore for the stake
 "Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo")
Zenotech to raise funds through rights issue
Drug firm Zenotech Laboratories is looking to raise funds through a rights issue to its existing shareholders. The company's Board of Directors have considered and approved the "raising of funds by way of offer and issue of equity shares to the existing shareholders of the company on a rights basis", Zenotech Laboratories said in a filing to BSE. While it did not disclose the amount to be raised, the company said its board has constituted a committee of directors for the purpose. The committee has been authorised "to determine terms of the rights issue including the quantum of issue, rights entitlement ratio, issue price, issue size, book closure or record date, entitlement, timing of the issue among others", it added. As per March 2016 shareholding pattern the promoter and promoter group hold 66.85 per cent shares in Zenotech Laboratories while public shareholding is at 33.15 per cent. Out of this Sun Pharmaceuticals Industries has 46.85 shares in the firm. Earlier in ...
